Department of Cancer Therapeutics, Institute of Cancer Research

Main Trials Page | Search Trials | Clinical Trial Site List | Drug Watch List

First-line Trials | Gleevec/Sutent-resistant | All Trials | Recruiting Trials | Preventative (Adjuvant)Treatment Trials

Trial Site Information
Site		Department of Cancer Therapeutics, Institute of Cancer Research			Go to their website
Address		Downs Rd
City		Sutton
State		Surrey
Zip		SM2 5PT
Country		UK

5 trials at this site

Phase	Trial	Trial Status	Site Status	Drug	NCT#
1	A Study Evaluating GDC-0980 Administered Once Daily in Patients With Refractory Solid Tumors or Non-Hodgkin's Lymphoma	Recruiting	Active	GDC-0980	NCT00854152

2	The Biological Activity of AZD2171 in GIST	Ongoing	Closed	AZD2171	NCT00385203

1	Phase 1 Study of OSI-930 in Cancer Patients	Ongoing	Closed	OSI-930	NCT00513851

1	Phase 1 Study of Intermittent OSI-906 Dosing	Ongoing	Closed	OSI-906	NCT00514306

1	Study of Oral CNF2024 in Advanced Solid Tumors	Completed	Closed	BIIB021 (CNF2024)	NCT00345189

NOTE: Trials marked as "Multiple Sites; see NEXTBIO/Clinicaltrials.gov" in the LRG database will not be listed on this page. These trials may have 20 to 150 sites recruiting.